Advertisement

Aluminum-induced “mixed” cell death in mice cerebral tissue and potential intervention

  • Yan-xia Hao
  • Mei-qin Li
  • Jing-si Zhang
  • Qin-li Zhang
  • Xia Jiao
  • Xiu-liang Ji
  • Huan Li
  • Qiao NiuEmail author
Original Article

Abstract

The brain is one of organs vulnerable to aluminum insult. Aluminum toxicity is involved in neurobehavioral deficit, neuronal cell dysfunction, and death. The aim of this study are as follows: (1) to evaluate the repairing efficiency of Necrostatin-1 (Nec-1), a cell death inhibitor, and Z-VAD-FMK, a pan-caspase inhibitor, on Al-induced neurobehavioral deficit and neuronal cell death, in order to evidence the cell death inducing ability of aluminum, and (2) to primarily explore the possibility of treating neuronal cell loss–related disease, such as Alzheimer’s disease, with Nec-1 and Z-VAD in Al-induced dementia animal model. We found Nec-1 and Z-VAD-FMK alone or in combination could reduce aluminum-induced learning and memory impairment in mice. Pathohistological results indicated that Nec-1 and Z-VAD-FMK can decrease Al-induced neuronal death cell. In addition, some cell death–associated proteins in cell death signal pathway were inhibited by Nec-1 and Z-VAD-FMK in Al-exposed mice. In conclusions, Nec-1 and Z-VAD-FMK can repair the injury of learning and memory induced by aluminum in mice. Furthermore, Nec-1 was more obvious to repair the injury of learning and memory function compared with Z-VAD-FMK. Nec-1 and Z-VAD-FMK can repair the Al-induced morphological injury of cell and reduce the amounts of dead cell, and repairing effects were more significant at higher doses. The effect of Nec-1 was stronger than Z-VAD-FMK, though their mechanism was different. The combination of them had the strongest effect. Our study evidenced Al-induced neuronal necroptosis and apoptosis existing in animal model and suggested potential therapeutic effects of Nec-1 and Z-VAD-FMK on neuronal cell death in neurodegenerative diseases.

Keywords

Necrostatin-1 Necroptosis Apoptosis Cell death Aluminum 

Notes

Funding Information

This study was supported by the Natural Science Foundation of China (NSFC, 81430078).

Compliance with Ethical Standards

This study was approved by the Ethics Committee for Animal Studies of Shanxi Medical University.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Barbara Kaltschmidt MU, Wellmann H, Volk B, Kaltschmidt C (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc Natl Acad Sci U S A 96(16):9409–9414CrossRefGoogle Scholar
  2. Bondy SC (2014) Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration. Toxicology 315:1–7CrossRefGoogle Scholar
  3. Cho YS (2018) The role of necroptosis in the treatment of diseases. BMB Rep 51(5):219–224CrossRefGoogle Scholar
  4. Christofferson DE, Li Y, Yuan J (2014) Control of life-or-death decisions by RIP1 kinase. Annu Rev Physiol 76:129–150CrossRefGoogle Scholar
  5. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112–119CrossRefGoogle Scholar
  6. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4(5):313–321CrossRefGoogle Scholar
  7. Degterev A, Zhou W, Maki JL, Yuan J (2014) Assays for necroptosis and activity of RIP kinases. Methods Enzymol 545:1–33CrossRefGoogle Scholar
  8. Esparza, J. L., M. Gómez and J. L. Domingo (2018). Role of melatonin in aluminum-related neurodegenerative disorders: a review. Biol Trace Elem Res.Google Scholar
  9. Exley C (2013) Human exposure to aluminium. Environ Sci Process Impacts 15(10):1807–1816CrossRefGoogle Scholar
  10. Green DR, Llambi F (2015) Cell death signaling. Cold Spring Harb Perspect Biol 7(12)Google Scholar
  11. Grootjans S, Vanden Berghe T, Vandenabeele P (2017) Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ 24(7):1184–1195CrossRefGoogle Scholar
  12. Haelewyn B, Alix P, Maubert E, Abraini JH (2008) NMDA-induced striatal brain damage and time-dependence reliability of thionin staining in rats. J Neurosci Methods 168(2):479–482CrossRefGoogle Scholar
  13. Humphries F, Yang S, Wang B, Moynagh PN (2015) RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ 22(2):225–236CrossRefGoogle Scholar
  14. Kim, M., A. Ho and J. H. Lee (2017). Autophagy and Human Neurodegenerative Diseases-A Fly’s Perspective. Int J Mol Sci 18(7).Google Scholar
  15. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2(8):589–598CrossRefGoogle Scholar
  16. Liu-Seifert H, Siemers E, Sundell K, Price K, Han B, Selzler K, Aisen P, Cummings J, Raskin J, Mohs R (2015) Cognitive and functional decline and their relationship in patients with mild Alzheimer’s dementia. J Alzheimers Dis 43(3):949–955CrossRefGoogle Scholar
  17. Neha Singla DKD (2013) Zinc, a neuroprotective agent against aluminum-induced oxidative DNA injury. Mol Neurobiol 48:1–12CrossRefGoogle Scholar
  18. Niu PY, Niu Q, Zhang QL, Wang LP, He SE, Wu TC, Conti P, Di Gioacchino M, Boscolo P (2005) Aluminum impairs rat neural cell mitochondria in vitro. Int J Immunopathol Pharmacol 18(4):683–689CrossRefGoogle Scholar
  19. Niu Q, Zhang Q, Niu P, Shi Y (2007) Study of neurocytes apoptosis in vitro culture rat induced by aluminum. Wei Sheng Yan Jiu 36(4):407–413PubMedGoogle Scholar
  20. Qinli Z, Meiqing L, Xia J, Li X, Weili G, Xiuliang J, Junwei J, Hailan Y, Ce Z, Qiao N (2013) Necrostatin-1 inhibits the degeneration of neural cells induced by aluminum exposure. Restor Neurol Neurosci 31(5):543–555PubMedGoogle Scholar
  21. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189CrossRefGoogle Scholar
  22. Silva AFJ, Aguiar MSS, Carvalho OSJ, Santana LDNS, Franco ECS, Lima RR, Siqueira NVMD, Feio RA, Faro LRF, Gomes-Leal W (2013) Hippocampal neuronal loss, decreased GFAP immunoreactivity and cognitive impairment following experimental intoxication of rats with aluminum citrate. Brain Res 1491:23–33CrossRefGoogle Scholar
  23. Singla N, Dhawan DK (2013) Zinc protection against aluminium induced altered lipid profile and membrane integrity. Food Chem Toxicol 55:18–28CrossRefGoogle Scholar
  24. Singla N, Dhawan DK (2015) Zinc down regulates Apaf-1-dependent Bax/Bcl-2 mediated caspases activation during aluminium induced neurotoxicity. Biometals 28(1):61–73CrossRefGoogle Scholar
  25. Singla N, Dhawan DK (2017) Zinc Improves cognitive and neuronal dysfunction during aluminium-induced neurodegeneration. Mol Neurobiol 54(1):406–422CrossRefGoogle Scholar
  26. Walton JR (2010) Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer’s disease. J Alzheimers Dis 22(1):65–72CrossRefGoogle Scholar
  27. Walton, J. R. (2012). CHAPTER 2: cognitive deterioration and related neuropathology in older people with Alzheimer’s disease could result from life-long exposure to aluminium compounds. Issues in Toxicology: 31-82.Google Scholar
  28. Walton JR (2014) Chronic aluminum intake causes Alzheimer’s disease: applying Sir Austin Bradford Hill’s causality criteria. J Alzheimers Dis 40(4):765–838CrossRefGoogle Scholar
  29. Wu J-R, Wang J, Zhou S-K, Yang L, Yin J-l, Cao J-P, Cheng Y-B (2015) Necrostatin-1 protection of dopaminergic neurons. Neural Regen Res 10(7):1120–1124CrossRefGoogle Scholar
  30. Xie T, Peng W, Liu Y, Yan C, Maki J, Degterev A, Yuan J, Shi Y (2013) Structural basis of RIP1 inhibition by necrostatins. Structure 21(3):493–499CrossRefGoogle Scholar
  31. Yang C, Li T, Xue H, Wang L, Deng L, Xie Y, Bai X, Xin D, Yuan H, Qiu J, Wang Z, Li G (2018) Inhibition of necroptosis rescues SAH-induced synaptic impairments in hippocampus via CREB-BDNF Pathway. Front Neurosci 12:990CrossRefGoogle Scholar
  32. Yang MH, Chen SC, Lin YF, Lee YC, Huang MY, Chen KC, Wu HY, Lin PC, Gozes I, Tyan YC (2019) Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer’s disease. J Food Drug Anal 27(2):551–564CrossRefGoogle Scholar
  33. Yukiko Kabeya NM, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagyosome membranes after processing. EMBO 19(21):5720–5728CrossRefGoogle Scholar
  34. Yumoto S, Kakimi S, Ohsaki A, Ishikawa A (2009) Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer’s disease. J Inorg Biochem 103(11):1579–1584CrossRefGoogle Scholar
  35. Zhang QL, Niu PY, Niu Q, Wang LP (2005) Effect of aluminum on neuronal mitochondria of rats. Wei Sheng Yan Jiu 34(6):674–677PubMedGoogle Scholar
  36. Zhang QL, Niu PY, Shi YT, Zhang HM, Wang F, Zhang L, Niu Q (2006) Role of Bcl-2 and Bax protein contents and their gene expression in Al-induced neurons apoptosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 24(10):582–586PubMedGoogle Scholar
  37. Zhang QL, Boscolo P, Niu PY, Wang F, Shi YT, Zhang L, Wang JWLP, Gioacchinol MDI, Conti P, Li QY, Niu Q (2008a) How do rat cortical cells cultured with aluminum die. Necrosis or apoptosis. Int J Immunopathol Pharmacol 21(I):107–115CrossRefGoogle Scholar
  38. Zhang QL, Niu Q, Ji XL, Conti P, Boscolo P (2008b) Is necroptosis a death pathway in aluminum-induced neuroblastoma cell demise? Int J Immunopathol Pharmacol 21(4):787–796CrossRefGoogle Scholar
  39. Zhang QL, Niu Q, Ji XL, Conti P, Boscolo P (2008c) Is necroptosis a death pathway in aluminum-induced neuroblastoma cell demise? International journal of immunopathology and pharmacology 21(4):787–796CrossRefGoogle Scholar
  40. Zhang Q, Li N, Jiao X, Qin X, Kaur R, Lu X, Song J, Wang L, Wang J, Niu Q (2014) Caspase-3 short hairpin RNAs a potential therapeutic agent in neurodegeneration of Al exposed animal model. Curr Alzheimer Res 11(10):961–970CrossRefGoogle Scholar
  41. Zhang H, Yang X, Qin X, Niu Q (2016) Caspase-3 is involved in aluminum-induced impairment of long-term potentiation in rats through the Akt/GSK-3beta pathway. Neurotox Res 29(4):484–494CrossRefGoogle Scholar
  42. Zilkova M, Koson P, Zilka N (2006) The hunt for dying neurons: insight into the neuronal loss in Alzheimer’s disease. Bratisl Lek Listy 107(9-10):366–373PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Occupational Health, Key Laboratory of Environmental Hazard and Health of Shanxi Province, Key Laboratory of Cellular Physiology of Ministry of EducationShanxi Medical UniversityTaiyuanPeople’s Republic of China
  2. 2.Shanxi Provincial People’s HospitalTaiyuanPeople’s Republic of China
  3. 3.University of Mississippi Medical CenterJacksonUSA

Personalised recommendations